Resistance Training After Menopause — Strength and Muscle Gains Hold Up

A common belief holds that after menopause, falling estrogen makes building strength or muscle futile or "not worth it." The best current pooled evidence does not support that.

The evidence. Isenmann et al. (2026, Journal of Science and Medicine in Sport) pooled 126 intervention studies covering 4,019 healthy women (66% postmenopausal; mean age of postmenopausal participants ~65) and compared training responses by menopausal status:

• Strength: large gains in both groups — premenopausal SMD 1.50 (95% CI 1.28–1.73), postmenopausal SMD 1.46 (95% CI 1.26–1.67) — no significant subgroup difference (p = 0.459). The same held when split into upper-body and lower-body strength.
• Functional mass (fat-free mass, lean body mass, and skeletal muscle mass combined): small but reliable gains in both — premenopausal SMD 0.27, postmenopausal SMD 0.30 — no subgroup difference (p = 0.520), with near-zero heterogeneity (I² = 0%).
• Fat mass: small reductions in both — premenopausal SMD 0.23, postmenopausal SMD 0.17 — no subgroup difference (p = 0.441).
• Meta-regressions found no association between outcomes and age, training duration, frequency, or total sessions.

Why it matters. Postmenopausal women with low muscle mass carry roughly a 2.1-fold higher fall risk and 2.7-fold higher bone-fracture risk than those with preserved muscle (per the same paper's introduction), and menopause accelerates bone loss (osteoporosis). The finding that training still works after menopause makes resistance training more important in this population, not less.

Honest limits.

• The meta-analysis pools within-group pre-to-post changes rather than head-to-head randomized comparisons, so its authors start the GRADE certainty rating at "low." Strength results were highly heterogeneous across studies (I² 77–92%) — the average effect is robust, individual responses vary widely.
• "Functional mass" combines several body-composition measures (mostly DEXA/BIA), not direct muscle-cross-section imaging, so it's a proxy for hypertrophy rather than a direct measurement of it.
• At least one smaller controlled trial disagrees on muscle growth: Isenmann et al. 2023 (BMC Women's Health; 31 women aged ~52 completed a 10-week free-weight program after a 10-week control phase, 2x/week, 6-8 sets per muscle per week) found 1RM squat and bench press rose in all groups, but fat-free mass, muscle mass, and rectus femoris thickness increased only in premenopausal women. Its authors conclude postmenopausal women likely need larger training volumes (>6-8 sets/muscle/week) for hypertrophy. Real counter-evidence at the single-study level — small and short, outweighed on the pooled question by the 126-study meta-analysis, but a meaningful practical hint: if muscle size (not just strength) is the goal after menopause, weekly volume may need to climb higher.

• 126 studies, 4,019 women: strength gains were statistically indistinguishable pre- vs postmenopause (SMD 1.50 vs 1.46, p = 0.459) (Isenmann et al. 2026).
• Lean/functional mass gains were also indistinguishable (SMD 0.27 vs 0.30, p = 0.520), as were fat-mass reductions (0.23 vs 0.17, p = 0.441).
• Age, training frequency, duration, and volume did not predict the size of adaptation in women.
• Certainty is limited by study design (pooled within-group changes), and one smaller trial found hypertrophy only premenopausally at 6-8 sets/muscle/week, with its authors suggesting postmenopausal women need more volume — directionally clear on strength, less settled on muscle size.

• considerations-by-sex — broader sex-specific considerations; covers menopause's bone-density effects, not training response.
• osteoporosis — menopause-accelerated bone loss, a key reason training matters in this population.
• older-adults — overlapping age-related training guidance.
• sex-differences-in-hypertrophy — the related "women can't/shouldn't build muscle" myth family.
• muscle-hypertrophy — the general growth mechanism.